Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $748.69 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stratus Medical, LLC | $214.30 | 1 | $0 (2024) |
| Vertiflex, Inc. | $179.64 | 3 | $0 (2018) |
| ABBVIE INC. | $164.02 | 5 | $0 (2024) |
| Nevro Corp. | $60.35 | 1 | $0 (2024) |
| Boston Scientific Corporation | $59.93 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.08 | 1 | $0 (2018) |
| Abbott Laboratories | $24.61 | 1 | $0 (2023) |
| ASSERTIO THERAPEUTICS, Inc. | $15.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $498.60 | 8 | Stratus Medical, LLC ($214.30) |
| 2023 | $24.61 | 1 | Abbott Laboratories ($24.61) |
| 2019 | $15.76 | 1 | ASSERTIO THERAPEUTICS, Inc. ($15.76) |
| 2018 | $209.72 | 4 | Vertiflex, Inc. ($179.64) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $59.93 | General |
| 11/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/26/2024 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $214.30 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 05/09/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $60.35 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/08/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Neuromodulation | ||||||
| 06/18/2019 | ASSERTIO THERAPEUTICS, Inc. | Gralise (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Neurology | ||||||
| 09/25/2018 | Vertiflex, Inc. | Superion ISS (Device) | Food and Beverage | In-kind items and services | $109.41 | General |
| Category: spinal stenosis | ||||||
| 09/04/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: PAIN MEDICINE | ||||||
| 08/23/2018 | Vertiflex, Inc. | Superion ISS (Device) | Food and Beverage | In-kind items and services | $59.58 | General |
| Category: spinal stenosis | ||||||
| 04/24/2018 | Vertiflex, Inc. | Superion ISS (Device) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: spinal stenosis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 865 | 1,914 | $691,755 | $165,848 |
| 2022 | 17 | 1,096 | 2,094 | $696,769 | $170,185 |
| 2021 | 15 | 1,207 | 2,323 | $645,096 | $169,344 |
| 2020 | 18 | 1,124 | 2,049 | $560,935 | $128,452 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 358 | 1,221 | $478,632 | $117,415 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 269 | $74,782 | $17,656 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $48,360 | $11,529 | 23.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 43 | 53 | $21,710 | $5,179 | 23.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 29 | 34 | $15,003 | $3,488 | 23.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 25 | 30 | $12,427 | $3,070 | 24.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 42 | $14,360 | $1,940 | 13.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 22 | 29 | $5,750 | $1,345 | 23.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 11 | 14 | $4,806 | $1,222 | 25.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 17 | 19 | $4,399 | $1,041 | 23.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 26 | 31 | $8,711 | $1,019 | 11.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $1,920 | $560.04 | 29.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 50 | 67 | $896.00 | $383.76 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 310 | 905 | $349,896 | $87,136 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 263 | 522 | $141,620 | $36,910 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 111 | 111 | $57,720 | $13,606 | 23.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 39 | 52 | $22,592 | $5,876 | 26.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 35 | 42 | $16,591 | $4,233 | 25.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 76 | 98 | $15,680 | $3,513 | 22.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 31 | 62 | $22,883 | $2,896 | 12.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 11 | 12 | $11,765 | $2,660 | 22.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 20 | 23 | $9,971 | $2,604 | 26.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 37 | 47 | $13,680 | $1,755 | 12.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 18 | 22 | $5,146 | $1,413 | 27.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 14 | 15 | $5,347 | $1,394 | 26.1% |
About Dr. Daniel Park, MD
Dr. Daniel Park, MD is a Pain Medicine healthcare provider based in North Dartmouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912117177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Park, MD has received a total of $748.69 in payments from pharmaceutical and medical device companies, with $498.60 received in 2024. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($748.69).
As a Medicare-enrolled provider, Park has provided services to 4,292 Medicare beneficiaries, totaling 8,380 services with total Medicare billing of $633,829. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location North Dartmouth, MA
- Active Since 05/23/2007
- Last Updated 01/22/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912117177
Products in Payments
- Nimbus (Device) $214.30
- Superion ISS (Device) $179.64
- BOTOX (Biological) $164.02
- Senza (Device) $60.35
- LUCEMYRA (Drug) $30.08
- OCTRODE (Device) $24.61
- Gralise (Drug) $15.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.